LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer

LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer

Non-small-cell lung carcinoma (NSCLC) is considered to be a fatal disease and characterized by a poor prognosis. Long non-coding RNAs (lncRNAs) have been reported to act as biomarkers and therapeutic targets in solid tumors. However, the expression of lncRNAs and their clinical relevance in NSCLC re...

Full description

Bibliographic Details
Main Authors:	Dexin Jia, Ying Xing, Yuning Zhan, Mengru Cao, Fanglin Tian, Weina Fan, Jian Huang, Yimeng Cui, Ruixue Gu, Yaowen Cui, Yuechao Liu, Shuai Zhang, Li Cai, Xiaomei Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	LINC02678 enhancer of zeste homolog 2 non-small-cell lung cancer proliferation epithelial-mesenchymal transition
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.686975/full

Similar Items

LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1
by: Li, S., et al.
Published: (2022)

LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2
by: Shuyao Zhang, et al.
Published: (2020-11-01)

MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2
by: Jing Chen, et al.
Published: (2017-02-01)

EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
by: Yatao Yin, et al.
Published: (2017-11-01)

Activation of miR-101-3p/EZH2 pathway enhances sorafenib sensitivity of HepG2 cells
by: ZHANG Yueting, et al.
Published: (2020-11-01)

Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
by: Cheng-Cao Sun, et al.
Published: (2016-01-01)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
by: Dou D, et al.
Published: (2019-11-01)

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
by: Wang C, et al.
Published: (2018-11-01)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
by: Tsung-Yun Hou, et al.
Published: (2017-07-01)

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
by: Cheng-Cao Sun, et al.
Published: (2020-09-01)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
by: Wang J, et al.
Published: (2020-09-01)

Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
by: BaoHan T. Vo, et al.
Published: (2017-03-01)

Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells
by: Yi-Chung Chien, et al.
Published: (2020-07-01)

Panobinostat and its combination with 3-deazaneplanocin-A induce apoptosis and inhibit In vitro tumorigenesis and metastasis in GOS-3 glioblastoma cell lines
by: Javier de la Rosa, et al.
Published: (2018-01-01)

Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2
by: Hanif Khan, et al.
Published: (2020-08-01)

LINC01414/LINC00824 genetic polymorphisms in association with the susceptibility of chronic obstructive pulmonary disease
by: Xiaoman Zhou, et al.
Published: (2021-07-01)

Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression
by: Li S, et al.
Published: (2018-06-01)

Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma
by: Wang WJ, et al.
Published: (2020-10-01)

EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
by: Liqiong Xue, et al.
Published: (2019-11-01)

LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer
by: Li Hua Zhang, et al.
Published: (2019-08-01)

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
by: De-Ning Ma, et al.
Published: (2016-01-01)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
by: Hu P, et al.
Published: (2019-11-01)

Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells
by: Kewei Xu, et al.
Published: (2013-06-01)

STAT3-Induced Upregulation of lncRNA CASC9 Promotes the Progression of Bladder Cancer by Interacting with EZH2 and Affecting the Expression of PTEN
by: Yuan B, et al.
Published: (2020-09-01)

Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma
by: Hanshuo Zhu, et al.
Published: (2021-01-01)

DiseaseLinc: Disease Enrichment Analysis of Sets of Differentially Expressed LincRNAs
by: Piyush More, et al.
Published: (2021-03-01)

Mixing and Matching Chromosomes during Female Meiosis
by: Thomas Rubin, et al.
Published: (2020-03-01)

EZH2 as a Regulator of CD8+ T Cell Fate and Function
by: Christopher J. Stairiker, et al.
Published: (2020-10-01)

Indirect Tumor Inhibitory Effects Of MicroRNA-124 Through Targeting EZH2 In The Multiple Myeloma Cell Line
by: Javid Sabour Takanlu, et al.
Published: (2020-04-01)

Polycomb Repressor Complex 2 in Genomic Instability and Cancer
by: Zoe Veneti, et al.
Published: (2017-07-01)

EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice
by: Lingling Wu, et al.
Published: (2021-03-01)

Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression
by: Lianyong Jiang, et al.
Published: (2020-05-01)

LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis
by: Zhang M, et al.
Published: (2019-05-01)

TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2
by: Qun Li, et al.
Published: (2019-01-01)

A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis
by: Hong Pan, et al.
Published: (2021-05-01)

Knockdown of LINC02471 Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375
by: Chen D, et al.
Published: (2020-09-01)

Knockdown of lincRNA PADNA promotes bupivacaine-induced neurotoxicity by miR-194/FBXW7 axis
by: Fan Yuning, et al.
Published: (2020-08-01)

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
by: Hao Gong, et al.
Published: (2020-12-01)

Índice de progreso social del distrito de Lince
by: Espinoza Ortiz, Judith Jakelyn, et al.
Published: (2019)